As of February 2024, we had some 18 projects in our pipeline. One of those projects resulted in the acquisition of Rosco Diagnostica. By April we have decided for 3 key projects and 4 runners up, which are in the areas of pharmaceuticals, diagnostics and supplements. Those we pursue towards the next steps whether acquisition, licensing or development
We aim to reduce about 10 projects to 1-2 key targets, which we will seek to pursue.
Please contact us on info@alpine-bio.com if you are a:
© 2024 Alpine-bio – Designed by Aveo web&marketing
We use cookies to optimize our website and our service.